(March 1, 2019) OCRA mourns the loss of our beloved board member and friend, Lori Newcomb. We are profoundly grateful for her vision and dedication in creating Newk’s Cares along with her loving husband, Chris, to support ovarian cancer research through their family business, Newk’s Eatery. Her unwavering and selfless commitment to help other women and to find a cure for this terrible disease is a testament to her incredible character. And her feisty, funny and infectious personality that shined so brightly will be sorely missed. Lori’s dedication and work to end ovarian cancer will live on through her legacy and will one day ensure that no other woman has to endure this terrible disease. Sending our love to Chris, Madison, Blair and Hayes.
Related Topics
OCRA Rivkin Family SummeRun Brings Together Nearly 1,000 Participants for a Day of Hope and Progress for Ovarian Cancer Research
Nearly 1,000 runners, walkers, survivors, families, friends, and supporters gathered at Seattle’s Seward Park on Sunday, July 12, 2026, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun. This year’s event raised more than $260,000. Now in its 33rd year, the event once again transformed the park into a sea of teal and purple, … Continued
OCRA Rivkin Family SummeRun Returns July 12 to Honor a Lasting Legacy and Fund Ovarian Cancer Research
SEATTLE, WA, July 9, 2026 — Nearly 1,000 runners, walkers, survivors, families, friends, and supporters are expected to gather at Seward Park on Sunday, July 12, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, one of the nation’s longest-running events dedicated to funding ovarian cancer research. Participants of all ages and abilities will transform … Continued
The Overview: June 2026
Nearly 500 people have already registered for OCRA’s International Gynecologic Cancer Conference®—the largest conference dedicated to the gynecologic cancer community—taking place on September 16–17. The conference is free, online, and open to all, and will include programming for ovarian, endometrial, cervical, and rare gynecologic cancers. For the first time, each of these diseases will have a dedicated Ask the Experts session. Learn … Continued
